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Acute myeloid leukemia (AML) is a disease known to be heavily reliant on its bone 34 
microenvironment (BMM) to survive and proliferate 1, 2. We have previously shown that 35 
AML disease progression is enabled by the transfer of functional mitochondria to the 36 
malignant cell from bone marrow stromal cells (BMSC) 3, 4. This process was shown 37 
to be stimulated by superoxide generated by NADPH oxidase-2 (NOX2) on the AML 38 
blast 3. However, beyond the stimulation of reactive oxygen species in BMSC, the 39 
mechanisms controlling mitochondrial transfer in BMSC have yet to be elucidated. 40 
 41 
There are no apparent adverse effects on BMSC after donation of mitochondria to 42 
AML blasts, implying the presence of a mechanism whereby the BMSC can recover 43 
their metabolic potential. The master regulator of mitochondrial biogenesis 5, 44 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1), has 45 
been implicated in cancer progression and metabolism 6, 7. In these studies, PGC-1 46 
is up-regulated and causes an increased accumulation of functional mitochondria. 47 
Here, we investigate the effect AML has on the mitochondrial mass, bio-energetic 48 
potential and PGC-1 expression in BMSC. 49 
 50 
First, using MitoTracker Green staining and flow cytometry, we determined the 51 
mitochondrial levels in primary BMSC (n=8) after co-culture with AML blasts. In Figure 52 
1A, we found significantly elevated mitochondrial levels in BMSC after co-culture, 53 
implying that AML blasts stimulate BMSC to produce more mitochondria. We next 54 
wanted to see if this increase in mitochondrial mass caused an increase in 55 
mitochondrial based metabolism. To do this we analysed BMSC oxygen consumption 56 
rate using the Seahorse extracellular flux assay. Increased mitochondrial respiration 57 
was observed in BMSC (n=4) after co-culture with AML blasts (Figure 1B and C). 58 
Moreover, in Figure 1D, we show that BMSC from patients with AML had increased 59 
mitochondrial respiration compared to BMSC from healthy individuals (n=3). Together, 60 
these results show that BMSC from patients with AML have increased mitochondrial 61 
mass and functional bio-energetic consequence in BMSC metabolism.  62 
 63 
As the transcription factor PGC-1 is known to cause increased mitochondrial 64 
biogenesis 5, we examined PGC1 expression in BMSC after co-culture with AML 65 
blasts. RNA expression of PGC-1 in BMSC (n=5) was increased in BMSC after co-66 
culture with AML blasts compared to BMSC cultured alone (Figure 1F). Next, we 67 
showed that total PGC-1 protein was elevated in BMSC after AML co-culture 68 
compared to control (Figure 1F). Moreover, we show that BMSC have increased 69 
nuclear levels of PGC-1 after co-culture with AML compared to BMSC cultured alone 70 
(Figure 1F), an effect which was reversed upon the addition of N-acetylcysteine to the 71 
co-culture (Supplementary figure 1). Previous studies have shown that AMPK can be 72 
stimulated by ROS 8 and in turn can stimulate PGC-1α 9. Therefore as NOX-2 derived 73 
ROS stimulates mitochondrial transfer to AML 3, we assessed whether AMPK is 74 
activated in BMSC after culture with AML blasts. We found increased phosphorylation 75 
of Thr182 in AMPK from BMSC after co-culture with AML blasts (Supplementary figure 76 
2).  Together, results from RNA and Western blotting highlight that AML blasts cause 77 
an increase in PGC-1 expression and localization in BMSC suggesting that PGC-1 78 
becomes activated via AMPK,  in response to AML co-culture.  79 
 80 
We next wanted to determine if elevated PGC-1 expression and nuclear localization 81 
and subsequent mitochondrial biogenesis was required for the mitochondrial transfer 82 
from BMSC to AML blasts. Figure 2A shows that mitochondrial transfer occurs from 83 
BMSC to the primary AML blasts. Next, we knocked down (KD) PGC-1 in BMSC with 84 
shRNA (Figure 2B). A MitoTracker Green based staining assay was then used to 85 
analyse the levels of mitochondrial transfer to AML blasts cultured on control KD and 86 
PGC-1 KD BMSC. Figure 2C shows that mitochondrial transfer from BMSC to AML 87 
is impaired when cultured on PGC-1 KD BMSC compared with control KD BMSC 88 
(Figure 2C). This data shows that PGC-1 activation is prerequisite for pro-tumoral 89 
mitochondrial transfer from BMSC to blasts in AML. 90 
 91 
To investigate the effect of PGC-1α on ROS and oxidative stress in BMSC, ROS levels 92 
in PGC-1α KD and control KD BMSC were analysed with and without AML co-culture. 93 
Basal ROS levels were elevated in BMSC when PGC-1α was knocked down 94 
(Supplementary figure 3A), however upon the addition of AML reduced ROS levels 95 
compared with control KD BMSC were observed (Supplementary figure 3B). 96 
Therefore, AML blasts are unable to stimulate ROS in PGC-1α KD BMSC to the same 97 
extent as control KD BMSC, which would account for the reduced mitochondrial 98 
transfer observed.  99 
Finally, we wanted to examine the effect PGC-1 KD in BMSC has on the disease 100 
progression of AML. To do this we used an NSG mouse model whereby we 101 
transplanted BMSC and AML blasts subcutaneously. Using this model, OCI-AML3 102 
cells tagged with a luciferase construct 10 and then subcutaneously injected with 103 
BMSC (into the right flank) and without BMSC (into the left flank), only proliferate in 104 
the presence of BMSC (Supplementary Figure 1).  We modified this model for use in 105 
the PGC-1 KD study, where we injected OCI-AML3 or MV4-11 luciferase cells with 106 
control KD BMSC (left flank) or PGC-1 KD BMSC (right flank). Figure 2D and 2E 107 
show that AML combined with PGC-1 KD BMSC has reduced tumor volume 108 
compared with animals with control KD BMSC. Figure 2F shows the bioluminescence 109 
from live animal imaging matches with excised tumors, where the tumors are reduced 110 
in the PGC-1 KD flank. Histologic analysis showed no difference between the AML 111 
tumors grown with PGC-1α KD BMSC compared to those that developed with control 112 
KD BMSC; with respect to the type or frequency of inflammatory cells or other non-113 
malignant cells (Supplementary figure 5). Overall it was observed that PGC-1 KD in 114 
BMSC has a negative effect on AML disease progression in vivo.  115 
 116 
In conclusion, this study provides a novel insight into the mechanisms controlling pro-117 
tumoral mitochondrial transfer in AML. We have shown that AML increases oxidative 118 
stress in the BMSC 3, and this causes an increase in PGC-1 expression and 119 
mitochondrial biogenesis in BMSC. This process is prerequisite for the pro-tumoral 120 
mitochondrial transfer from BMSC to leukemic blasts observed in AML. Inhibition of 121 
PGC-1 in BMSC reduces the trafficking of mitochondria and thus limits the 122 
proliferative capacity of the tumor. As pro-tumoral mitochondrial transfer is increasingly 123 
recognised as part of the malignant phenotype in multiple cancers 11-13, this study 124 
provides a novel mechanistic insight as to how PGC-1 may be targeted in the 125 
microenvironment as a means to limiting mitochondrial transfer to cancer. Treatments 126 
inhibiting mitochondrial metabolism and function in AML blasts, including IDH1/2 127 
mutant inhibitors 14 and the Bcl-2 inhibitor venetoclax, have recently been shown to be 128 
clinically effective 15. This study also provides an important step in understanding the 129 
complex nature of tumor metabolism, not only in the malignant cell, but also within the 130 
microenvironment which supports it. 131 
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Figure legends 234 
 235 
Figure 1. AML stimulates mitochondrial biogenesis in BMSC through PGC-1 236 
(A) BMSC were cultured with AML blasts for 24 hours, then BMSC (n=8) were stained 237 
with 200 nM MitoTracker Green FM. Mitochondrial levels were analysed using 238 
MitoTracker Green mean fluorescence intensity by flow cytometry. (B) A 239 
representative plot of oxygen consumption rate from the Seahorse MitoStress assay. 240 
Oligomycin (O), FCCP (F) and rotenone (R) were injected periodically and oxygen 241 
consumption rate was measured. (C and D) Basal and maximum mitochondrial 242 
respiration in BMSC cultured with and without AML blasts (C) and from AML and 243 
healthy patients (D) (n=3). (E) RNA qPCR analysis of BMSC (n=5) with and without 244 
co-culture with AML blasts. (F) Western blot analysis of nuclear, cytosolic and total 245 
PGC-1 protein from BMSC (n=2) cultured with and without AML blasts (n=2).  246 
 247 
Figure 2. PGC-1 is crucial for mitochondrial transfer and AML disease 248 
progression. 249 
(A) MitoTracker Green based transfer assay showing that AML blasts, used in this 250 
study, have acquired mitochondria from BMSC. (B) PGC-1 RNA expression is 251 
significantly reduced in BMSC after specific lentiviral targeting. (C) Mitochondrial 252 
transfer levels to AML blasts are reduced when cultured on PGC-1 KD BMSC. (D) 253 
Schematic representation of the NSG mouse model used. (E) Bioluminescent live 254 
animal images showing OCI-AML3/MV4-11 AML disease progression, when injected 255 
subcutaneously with control KD or PGC-1α BMSC. (F) Quantification of 256 
bioluminescent images seen in E (OCI-AML3; n=5. MV4-11; n=4). (G) Excised tumors 257 
were measured using calipers. 258 
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